RCUS
Arcus Biosciences, Inc.
NYSE · Healthcare · Biotechnology · US
$29.66
−1.56%0
Insider buys (3m)
8
Insider sells (3m)
-$3.0M
Net value (3m)
+27.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 24, 2026 | Azoy Alexander · officer: Chief Accounting Officer | Sale | 2,827 | $30 |
| Aug 24, 2026 | Azoy Alexander · officer: Chief Accounting Officer | M-Exempt | 2,827 | $15 |
| Jul 13, 2026 | Jaen Juan C. · officer: President | Sale | 48,502 | $30 |
| Jul 13, 2026 | Jaen Juan C. · officer: President | Sale | 268 | $29 |
| Jul 13, 2026 | Jaen Juan C. · officer: President | Sale | 19,799 | $29 |
| Jun 24, 2026 | Jaen Juan C. · officer: President | Sale | 9,236 | $27 |
| Jun 24, 2026 | Jaen Juan C. · officer: President | Sale | 6,431 | $30 |
| Jun 24, 2026 | Jaen Juan C. · officer: President | Sale | 14,067 | $28 |
| Jun 24, 2026 | Jaen Juan C. · officer: President | Sale | 1,697 | $28 |
| Jun 12, 2026 | PERLMAN ANDREW J · director | A-Award | 5,700 | $0.00 |
| Jun 12, 2026 | KANEKO YASUNORI · director | A-Award | 16,900 | $23 |
| Jun 12, 2026 | Ribas Antoni · director | A-Award | 5,700 | $0.00 |
| Jun 12, 2026 | Lacey David L. · director | A-Award | 16,900 | $23 |
| Jun 12, 2026 | Lacey David L. · director | A-Award | 5,700 | $0.00 |
| Jun 12, 2026 | Tang Carolyn C. · officer: General Counsel | M-Exempt | 34,090 | $2.57 |
| Jun 12, 2026 | Lambert Nicole · director | A-Award | 5,700 | $0.00 |
| Jun 12, 2026 | Ribas Antoni · director | A-Award | 16,900 | $23 |
| Jun 12, 2026 | PERLMAN ANDREW J · director | A-Award | 16,900 | $23 |
| Jun 12, 2026 | Machado Patrick · director | A-Award | 5,700 | $0.00 |
| Jun 12, 2026 | Machado Patrick · director | A-Award | 16,900 | $23 |
| Jun 12, 2026 | Lambert Nicole · director | A-Award | 16,900 | $23 |
| Jun 12, 2026 | KANEKO YASUNORI · director | A-Award | 5,700 | $0.00 |
| Jun 12, 2026 | FALBERG KATHRYN E · director | A-Award | 5,700 | $0.00 |
| Jun 12, 2026 | FALBERG KATHRYN E · director | A-Award | 16,900 | $23 |
| Jun 1, 2026 | Azoy Alexander · officer: Chief Accounting Officer | Sale | 2,562 | $26 |
| May 12, 2026 | Goeltz II Robert C. · officer: Chief Financial Officer | Sale | 7,763 | $26 |
| Jan 26, 2026 | Jarrett Jennifer · officer: Chief Operating Officer | A-Award | 126,000 | $22 |
| Jan 26, 2026 | Jaen Juan C. · officer: President | A-Award | 126,000 | $22 |
| Jan 26, 2026 | Jarrett Jennifer · officer: Chief Operating Officer | A-Award | 31,000 | $0.00 |
| Jan 26, 2026 | Azoy Alexander · officer: Chief Accounting Officer | A-Award | 14,050 | $22 |
Institutional positioning
13F filings over the trailing two quarters
New 85Increased 172Reduced 124Sold out 24
| Filer | Action | Shares | Filed |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Unchanged | 31,424,760 | May 8, 2026 |
| GILEAD SCIENCES, INC. | Unchanged | 31,424,760 | Aug 3, 2026 |
| BlackRock, Inc. | Increased | 16,416,249 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 15,226,475 | May 13, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 6,089,516 | May 15, 2026 |
| STATE STREET CORP | Increased | 6,029,484 | Aug 7, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 5,895,448 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 5,412,901 | May 15, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Reduced | 5,030,993 | May 15, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Reduced | 4,776,423 | Aug 14, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 4,475,528 | Aug 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 4,272,056 | May 8, 2026 |
| FMR LLC | Increased | 4,049,757 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 3,888,346 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 3,856,725 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 24, 2026